Accounting reportsPreviously
|
Name | AKTSIONERNOE OBSCHESTVO "EMOKSIFARM" |
|---|
INN | 7713764354 |
|---|
KPP | 770301001 |
|---|
OGRN | 1137746196059 |
|---|
OKPO | 17269114 |
|---|
Address | 123112, G.MOSKVA, ul. Testovskaya, d. 10, pomesch. 1/16 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 46.46.1 | Core activity | Wholesale of furniture, carpets and lighting equipment | | 46.18.1 | Additional activity | Agents specialized in the wholesale trade of pharmaceutical products, products used for medical purposes, perfume and cosmetics, including soap and detergents | | 46.46.2 | Additional activity | Wholesale of medical and orthopedic goods, dental and laboratory supplies | | All types of activities | | 46.69.8 | Additional activity | Wholesale trade machinery, equipment and tools used for medical purposes | | 69.20 | Additional activity | Auditing and tax consulting, bookkeeping | | 70.22 | Additional activity | Advice on business and management | | 74.20 | Additional activity | Interior Design and Interior Design | | 74.30 | Additional activity | Translation and interpretation activities | | 82.92 | Additional activity | Activities of packing goods |
Registration date | 06.03.2013 |
|---|
|
AO "EMOKSIFARM" (Moscow; INN 7713764354) was registered on 6 Mar 2013. The company's authorized capital as of July 1, 2012 was 10000 rub. Principal activities of AO "EMOKSIFARM": wholesale of furniture, carpets and lighting equipment (46.46.1), agents specialized in the wholesale trade of pharmaceutical products, products used for medical purposes, perfume and cosmetics, including soap and detergents (46.18.1), wholesale of medical and orthopedic goods, dental and laboratory supplies (46.46.2). |
Economic indicators2023
Net loss (RA) of AO EMOKSIFARM made up 457.98 million RUB over 2023 compared to net profit of 224.05 million RUB over 2022, the company informed. Revenue increased in the accounting period 1.56 times to 737.58 million RUB from 472.54 million RUB over 2022; cost of goods sold grew 2.31 times to 236.94 million RUB from 102.74 million RUB; sales profit went up by 39.24% to 399.60 million RUB from 286.98 million RUB. 2022
Net profit (RAS) of AO EMOKSIFARM dropped in 2022 by 25.24% to 224.05 million RUB from 299.71 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 18.19% to 472.54 million RUB from 577.60 million RUB in 2021; cost of goods sold decreased by 7.44% to 102.74 million RUB from 111.00 million RUB; sales profit fell by 23.31% to 286.98 million RUB from 374.20 million RUB. 2021
Net profit (RAS) of AO EMOKSIFARM grew over 2021 3.07 times to 299.71 million RUB from 97.59 million RUB over 2020, the company informed. Revenue increased in the accounting period 2.77 times to 577.60 million RUB from 208.27 million RUB over 2020; cost of goods sold grew 2.19 times to 111.00 million RUB from 50.79 million RUB; sales profit went up 2.87 times to 374.20 million RUB from 130.55 million RUB. 2020
Net profit (RAS) of AO EMOKSIFARM grew over 2020 8.86 times to 97.59 million RUB from 11.02 million RUB over 2019, the company informed. Revenue increased in the accounting period 9.34 times to 208.27 million RUB from 22.30 million RUB over 2019; cost of goods sold grew 14.19 times to 50.79 million RUB from 3.58 million RUB; sales profit went up 8.12 times to 130.55 million RUB from 16.08 million RUB. 2019
Net profit (RAS) of AO EMOKSIFARM grew over 2019 by 10.47% to 11.02 million RUB from 9.97 million RUB over 2018, the company informed. Revenue increased in the accounting period by 5.95% to 22.30 million RUB from 21.05 million RUB over 2018; cost of goods sold remained at the same level amounting to 3.58 million RUB compared to 3.57 million RUB; sales profit went up by 7.00% to 16.08 million RUB from 15.03 million RUB. 2018
Net profit (RAS) of AO EMOKSIFARM dropped in 2018 by 12.29% to 9.97 million RUB from 11.37 million RUB over the same period in 2017, the company informed. Revenue decreased in the accounting period by 5.72% to 21.05 million RUB from 22.33 million RUB in 2017; cost of goods sold remained at the same level amounting to 3.57 million RUB compared to 3.57 million RUB; sales profit fell by 11.34% to 15.03 million RUB from 16.95 million RUB. 2017
Net profit (RAS) of AO EMOKSIFARM made up 11.37 million RUB over 2017 compared to net loss of 2.27 million RUB over 2016, the company informed. Revenue increased in the accounting period 4.56 times to 22.33 million RUB from 4.89 million RUB over 2016; cost of goods sold remained at the same level amounting to 3.57 million RUB compared to 3.57 million RUB; sales profit made up 16.95 million RUB compared to sales loss of 349.00 thousand RUB. 2016
Net loss (RAS) of AO EMOKSIFARM dropped over 2016 by 7.90% to 2.27 million RUB from 2.47 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 17.94% to 4.89 million RUB from 4.15 million RUB over 2015; cost of goods sold remained at the same level amounting to 3.57 million RUB compared to 3.57 million RUB; sales loss grew by 37.94% to 349.00 thousand RUB from 253.00 thousand RUB. 2014
Net loss (RAS) of Emoksifarm, ZAO increased 2.21 times to 3.74 million RUB from 1.70 million RUB over 2013, the company informed. Sales loss grew 6.35 times to 1.58 million RUB from 248.00 thousand RUB. 2013
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|